Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Boston Scientific (BSX) PT Raised to $26 at Oppenheimer Following Solid 4Q
February 3, 2017 9:47 AM ESTOppenheimer raised its price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.00) while maintaining a Perform rating following the company's 4Q report.
Analyst Steven Lichtman commented, "BSX delivered strong, broad-based sales growth in 4Q16 and continued solid operating margin expansion. Sales in the quarter... More
Boston Scientific (BSX) Tops Q4 EPS by 1c
February 2, 2017 6:31 AM ESTBoston Scientific (NYSE: BSX) reported Q4 EPS of $0.30, $0.01 better than the analyst estimate of $0.29. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.16 billion.
"Boston Scientific delivered excellent financial results in 2016, with accelerated revenue growth, improved profitability, and... More
